the present invention discloses that a method of treating cancer , preferably non - small cell lung cancer , comprises administrating mitoxantrone . the present invention also discloses a method of inhibiting ros1 kinase comprising administrating mitoxantrone . a pharmaceutical composition comprising mitoxantrone is also disclosed .